These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 38232906)

  • 1. Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
    Ebrahimzadeh A; Mohseni S; Safargar M; Mohtashamian A; Niknam S; Bakhoda M; Afshari S; Jafari A; Ebrahimzadeh A; Fooladshekan S; Mohtashami A; Ferns GA; Babajafari S; Sohrabi Z
    Complement Ther Med; 2024 Mar; 80():103025. PubMed ID: 38232906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Jalali M; Mahmoodi M; Mosallanezhad Z; Jalali R; Imanieh MH; Moosavian SP
    Complement Ther Med; 2020 Jan; 48():102283. PubMed ID: 31987259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of curcumin/turmeric supplementation on the liver enzymes, lipid profiles, glycemic index, and anthropometric indices in non-alcoholic fatty liver patients: An umbrella meta-analysis.
    Molani-Gol R; Dehghani A; Rafraf M
    Phytother Res; 2024 Feb; 38(2):539-555. PubMed ID: 37918958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of curcumin on anthropometric and cardiometabolic parameters of patients with metabolic related diseases: a systematic review and dose-effect meta-analysis of randomized controlled trials.
    Sun Z; Wei X; Bai J; Li W; Yang J; Deng Z; Wu M; Ying T; He G
    Crit Rev Food Sci Nutr; 2023; 63(28):9282-9298. PubMed ID: 35475714
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials.
    Baziar N; Parohan M
    Phytother Res; 2020 Mar; 34(3):464-474. PubMed ID: 31799714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Nowrouzi-Sohrabi P; Rezaei S; Jalali M; Ashourpour M; Ahmadipour A; Keshavarz P; Akbari H
    Eur J Pharmacol; 2021 Feb; 893():173823. PubMed ID: 33352183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary polyphenol curcumin supplementation on metabolic, inflammatory, and oxidative stress indices in patients with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Qiu L; Gao C; Wang H; Ren Y; Li J; Li M; Du X; Li W; Zhang J
    Front Endocrinol (Lausanne); 2023; 14():1216708. PubMed ID: 37522129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of saffron supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis.
    Zamani M; Zarei M; Nikbaf-Shandiz M; Gholami F; Hosseini AM; Nadery M; Shiraseb F; Asbaghi O
    Front Nutr; 2022; 9():1055517. PubMed ID: 36570145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of curcumin/turmeric supplementation on glycemic indices in adults: A grade-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Dehzad MJ; Ghalandari H; Nouri M; Askarpour M
    Diabetes Metab Syndr; 2023 Oct; 17(10):102855. PubMed ID: 37748368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Turmeric/curcumin Supplementation Change Anthropometric Indices in Patients with Non-alcoholic Fatty Liver Disease? A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Jafarirad S; Mansoori A; Adineh A; Panahi Y; Hadi A; Goodarzi R
    Clin Nutr Res; 2019 Jul; 8(3):196-208. PubMed ID: 31384598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials.
    Wang Y; Wang Y; Shehzad Q; Su Y; Xu L; Yu L; Zeng W; Fang Z; Wu G; Wei W; Jin Q; Zhang H; Wang X
    Crit Rev Food Sci Nutr; 2024 Sep; 64(26):9455-9482. PubMed ID: 37222574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of curcumin/turmeric supplementation on lipid profile: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Dehzad MJ; Ghalandari H; Amini MR; Askarpour M
    Complement Ther Med; 2023 Aug; 75():102955. PubMed ID: 37230418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Nano-Curcumin Supplementation on Risk Factors for Cardiovascular Disease: A GRADE-Assessed Systematic Review and Meta-Analysis of Clinical Trials.
    Ashtary-Larky D; Rezaei Kelishadi M; Bagheri R; Moosavian SP; Wong A; Davoodi SH; Khalili P; Dutheil F; Suzuki K; Asbaghi O
    Antioxidants (Basel); 2021 Jun; 10(7):. PubMed ID: 34202657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    Nutr Metab (Lond); 2019; 16():8. PubMed ID: 30705687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of probiotic and synbiotic supplementation on some cardiovascular risk factors among individuals with prediabetes and type 2 diabetes mellitus: A grade-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials.
    Naseri K; Saadati S; Yari Z; Asbaghi O; Hezaveh ZS; Mafi D; Hoseinian P; Ashtary-Larky D; Hekmatdoost A; de Courten B
    Pharmacol Res; 2022 Aug; 182():106288. PubMed ID: 35680009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vitamin D2 on lipid profile, anthropometric indices, blood pressure, and inflammatory and glycemic biomarkers in humans: A systematic review and meta-analysis of randomized controlled trials.
    Zhou Z; Liu J; Zhang H; Prabahar K; Hernández-Wolters B; Yuan Y
    Prostaglandins Other Lipid Mediat; 2024 Oct; 174():106883. PubMed ID: 39154789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of synbiotics on liver enzymes, obesity indices, blood pressure, lipid profile, and inflammation in patients with non-alcoholic fatty liver: A systematic review and meta-analysis of randomized controlled trials.
    Musazadeh V; Assadian K; Rajabi F; Faghfouri AH; Soleymani Y; Kavyani Z; Najafiyan B
    Pharmacol Res; 2024 Oct; 208():107398. PubMed ID: 39241935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.